ClinicalTrials.gg
CompletedNCT03383744Updated Dec 26, 2017

Using Stable Isotopes to Assess the Effectiveness of Vitamin A Supplementation in Cameroon

An interventional study of vitamin A supplementation in Vitamin A Deficiency, sponsored by Centre for Food and Nutrition Research, Yaounde. Completed. Open to participants aged 3 Years to 5 Years. Per ClinicalTrials.gov, last updated 2017-12-26.

Sponsored by Centre for Food and Nutrition Research, Yaounde · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Oct 2015, registered Dec 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
3 Years to 5 Years
Sex
All
01

Study summary

This is a study to evaluate the effects of vitamin A supplementation program on the vitamin A status of preschool children. All children aged 3-5 years who do not have severe illness and are not planning to move from the study area are eligible. Children whose caregivers agree to sign the consent form will be enrolled in their community and submitted to a longitudinal evaluation of vitamin A status before and after vitamin A supplementation campaign.

Vitamin A status will be assessed by measuring serum retinol, retinol binding protein and vitamin A total body pool size using stable isotope dilution methodology.

Read the detailed description

Five months after the last supplementation (day 0), an oral dose (2 mg retinol equivalents) of label vitamin A ([2H8]-retinyl acetate) in oil will be administered to 80 eligible children together with a low vitamin A high-fat snack. Fasting venous blood samples (about 7 ml) will be collected into evacuated foil-wrapped blood collection tubes specifically designed for the collection of serum (containing no anticoagulant and metal free) on the mornings of days 0 before the administration of the dose and on day 14 for quantitative estimation of initial vitamin A pool size and determination of potential confounding parameters (CRP, AGP, iron, zinc, malaria, carotenoids and retinoids). About six months after the last supplementation (day 30), each child will received the vitamin A supplement. After 30 days and 90 days, two groups of 40 children (Grp1, Grp2) will respectively received a second dose of labeled vitamin A ([2H4]-retinyl acetate); fasting venous blood samples will be obtained before the administration of the dose and 14 days after dosing for quantitative estimation of final vitamin A pool size and determination of potential confounding parameters.

02

Conditions studied

  • Vitamin A Deficiency

Browse trials for

03

In context

Vitamin A Deficiency

67 studies on the registry are indexed under Vitamin A Deficiency; 7 are open to participants now.

This study's enrollment of 104 is below the median of 200 across 49 interventional studies indexed under Vitamin A Deficiency.

Browse Vitamin A Deficiency studies →

Lead sponsor

Centre for Food and Nutrition Research, Yaounde is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children will be included if they are in the target age range (36-59 months), are not planning to move from the study area for the duration of the study and do not have severe illness at the time of enrolment

Exclusion criteria

Exclusion Criteria:

  • Exclusion criteria will generally include the following conditions: severe anaemia, severe acute malnutrition, obesity, or clinically defined severe illness, such as dehydration, severe diarrhoea, malaria or severe respiratory illness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
104 participants (actual)

Study arms

  • Experimental
    Vitamin A supplementation 1

    Vitamin A status assessed at Baseline and one month after the administration of 200,000 IU of vitamin A

    Dietary Supplement: vitamin A supplementation

  • Experimental
    Vitamin A supplementation 3

    Vitamin A status assessed at Baseline and three months after the administration of 200,000 IU of vitamin A

    Dietary Supplement: vitamin A supplementation

Interventions

  • Dietary supplementvitamin A supplementation

    Each child received one capsule of 200,000 IU of vitamin A

06

What researchers measure

Primary outcomes

  1. Change in vitamin A status at one month

    Change from Baseline vitamin A total body stores at one month

    Time frame: One month after vitamin A supplementation

  2. Change in vitamin A status at 3 months

    Change from Baseline vitamin A total body stores at 3 months

    Time frame: 3 months after vitamin A supplementation

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Imdad A, Mayo-Wilson E, Haykal MR, Regan A, Sidhu J, Smith A, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2022 Mar 16;3(3):CD008524. doi: 10.1002/14651858.CD008524.pub4. PubMed 35294044 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2015 to primary completion in Mar 2016, 5 months.

Of 19 interventional studies with no phase under Vitamin A Deficiency, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 26. This study's 5 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 16, 2017
First posted
Dec 26, 2017
StartActual
Oct 5, 2015
Primary completionActual
Mar 23, 2016
CompletionActual
Jul 29, 2016
Last update
Dec 26, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 26, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03383744
Lead sponsor
Centre for Food and Nutrition Research, Yaounde
Collaborators
International Atomic Energy Agency
Responsible party
Medoua Nama Gabriel (Head of Centre, Centre for Food and Nutrition Research, Yaounde) — Principal investigator
First posted
Dec 26, 2017
Start date
Oct 5, 2015
Primary completion
Mar 23, 2016
Completion
Jul 29, 2016
Last update
Dec 26, 2017

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion